SELCIA

• 72110 - Research and experimental development on biotechnology

Selcia is a global contract research provider of integrated drug discovery, medicinal chemistry and 14C radiolabeled compounds. Established in 2001, the company has two divisions: Selcia Drug Discovery - with medicinal chemistry,biology ADME and a unique peptidyl proyl isomerase (PPIase) inhibitor screening platform; and Selcia Radiolabeling - one of the world's largest suppliers of custom 14C radiochemicals... Selcia is a fast growing, successful and profitable organisation.Since 2005, our turnover has grown by more than 100 per cent... Selcia provides integrated drug discovery services and high quality 14C radiolabelled compounds to pharma, biotechnology companies and academic institutions

Also known as: EUROFINS SELCIA LIMITED, Selcia Limited, Selcia Ltd.

Previous names: SCYNEXIS EUROPE LIMITED, SELCIA LIMITED

Registration numbers: 04172701 (CH)

Primary location: Ongar United Kingdom